GBP10.66
1.66% yesterday
London, Jul 01, 05:30 pm CET
ISIN
GB00BN4HT335
Symbol
INDV
Sector
Industry

Indivior Stock price

GBP10.69
+1.53 16.70% 1M
+0.45 4.39% 6M
+0.45 4.39% YTD
-1.61 13.09% 1Y
-4.54 29.81% 3Y
+6.78 173.23% 5Y
-0.14 1.26% 10Y
+3.51 48.90% 20Y
London, Closing price Tue, Jul 01 2025
-0.15 1.38%
ISIN
GB00BN4HT335
Symbol
INDV
Sector
Industry

Key metrics

Basic
Market capitalization
GBP1.3b
Enterprise Value
GBP1.2b
Net debt
positive
Cash
GBP271.6m
Shares outstanding
125.0m
Valuation (TTM | estimate)
P/E
negative | 11.35
P/S
0.85 | 1.63
EV/Sales
0.82 | 1.59
EV/FCF
12.87
P/B
negative
Dividends
DPS
GBP0.00
Yield 1Y | 5Y
0.00% | 0.00%
Growth 1Y | 5Y
- | -
Payout 1Y | 3Y
0.00% | 0.00%
Increased
0 Years
Financials (TTM | estimate)
Revenue
GBP1.5b | GBP777.1m
EBITDA
GBP406.4m | GBP202.0m
EBIT
GBP388.2m
Net Income
GBP-40.1m | GBP119.3m
Free Cash Flow
GBP96.1m
Growth (TTM | estimate)
Revenue
83.27% | -10.18%
EBITDA
93.75% | -4.34%
EBIT
107.39%
Net Income
-1,200.27% | 8,073.97%
Free Cash Flow
134.46%
Margin (TTM | estimate)
Gross
83.98%
EBITDA
27.09% | 26.00%
EBIT
25.87%
Net
-2.67% | 15.36%
Free Cash Flow
6.41%
Financial Health
Equity Ratio
-26.38%
Return on Equity
-0.57%
ROCE
144.05%
ROIC
57.89%
Debt/Equity
-1.15
More
EPS
GBP-0.32
FCF per Share
GBP0.77
Short interest
175.00%
Employees
1.04k
Rev per Employee
GBP830.00k
Show more

Is Indivior a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,951 stocks worldwide.

Indivior Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Indivior forecast:

7x Buy
88%
1x Hold
13%

Analyst Opinions

8 Analysts have issued a Indivior forecast:

Buy
88%
Hold
13%

Financial data from Indivior

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
1,500 1,500
83% 83%
100%
- Direct Costs 240 240
71% 71%
16%
1,260 1,260
86% 86%
84%
- Selling and Administrative Expenses 737 737
78% 78%
49%
- Research and Development Expense 130 130
66% 66%
9%
406 406
94% 94%
27%
- Depreciation and Amortization 18 18
19% 19%
1%
EBIT (Operating Income) EBIT 388 388
107% 107%
26%
Net Profit -40 -40
1,200% 1,200%
-3%

In millions GBP.

Don't miss a Thing! We will send you all news about Indivior directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Indivior PLC is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in Slough, the United Kingdom.

Head office United Kingdom
CEO Joseph Ciaffoni
Employees 1,041
Founded 2014
Website www.indivior.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today